- Investing Ideas
- U.S. Biotech Stocks
U.S. Biotech Stocks
Results
466
Even though biotechnology stocks can be very risky, they can also offer some of the biggest rewards with huge profits on offer when you find the right one. The companies below all have reasonable balance sheets and value, giving the best chance of finding a gem.
466 companies
Eli Lilly
Market Cap: US$945.7b
Eli Lilly and Company discovers, develops, manufactures, and markets human pharmaceutical products in the United States, Europe, China, Japan, and internationally.
LLY
US$1,042.15
7D
0.6%
1Y
15.6%
Johnson & Johnson
Market Cap: US$592.4b
Engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide.
JNJ
US$246.28
7D
1.2%
1Y
48.3%
AbbVie
Market Cap: US$405.8b
A research-based biopharmaceutical company, engages in the research and development, manufacturing, commercializing, and sale of medicines and therapies worldwide.
ABBV
US$228.44
7D
-1.9%
1Y
11.9%
Merck
Market Cap: US$307.3b
Operates as a healthcare company worldwide.
MRK
US$123.93
7D
1.9%
1Y
35.5%
Amgen
Market Cap: US$204.5b
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide.
AMGN
US$382.87
7D
2.5%
1Y
21.3%
Thermo Fisher Scientific
Market Cap: US$194.0b
Provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally.
TMO
US$515.60
7D
2.8%
1Y
-4.4%
Gilead Sciences
Market Cap: US$185.9b
A biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.
GILD
US$147.64
7D
-4.9%
1Y
32.4%
Pfizer
Market Cap: US$153.9b
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally.
PFE
US$27.14
7D
-0.8%
1Y
1.5%
Danaher
Market Cap: US$149.1b
Designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally.
DHR
US$209.19
7D
1.4%
1Y
-0.6%
Bristol-Myers Squibb
Market Cap: US$124.7b
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide.
BMY
US$61.60
7D
2.1%
1Y
5.8%
Vertex Pharmaceuticals
Market Cap: US$122.2b
Operates as a biotechnology company in the United States, Europe, and internationally.
VRTX
US$487.43
7D
2.1%
1Y
1.5%
Regeneron Pharmaceuticals
Market Cap: US$80.8b
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines to treat various diseases worldwide.
REGN
US$772.19
7D
-2.7%
1Y
6.7%
Zoetis
Market Cap: US$53.1b
Engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health solutions for the animal health industry in the United States and internationally.
ZTS
US$128.66
7D
2.5%
1Y
-23.7%
Alnylam Pharmaceuticals
Market Cap: US$43.7b
Alnylam Pharmaceuticals, Inc. discovers, develops, manufactures, and commercializes therapeutics based on ribonucleic acid interference in the United States, Europe, and internationally.
ALNY
US$332.85
7D
0.07%
1Y
35.7%
BeOne Medicines
Market Cap: US$41.0b
An oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe, and internationally.
ONC
US$369.00
7D
4.0%
1Y
42.1%
Teva Pharmaceutical Industries
Market Cap: US$39.5b
Develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally.
TEVA
US$33.92
7D
-1.4%
1Y
104.2%
Agilent Technologies
Market Cap: US$35.1b
Provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide.
A
US$124.40
7D
0.4%
1Y
-7.3%
Insmed
Market Cap: US$34.3b
Develops and commercializes therapies for patients with serious and rare diseases in the United States, Europe, Japan, and internationally.
INSM
US$158.62
7D
5.4%
1Y
104.7%
Waters
Market Cap: US$32.2b
Provides analytical workflow solutions in Asia, the Americas, and Europe.
WAT
US$326.30
7D
1.5%
1Y
-14.3%
Natera
Market Cap: US$29.0b
A diagnostics company, provides molecular testing services worldwide.
NTRA
US$209.53
7D
-0.8%
1Y
34.3%
Biogen
Market Cap: US$28.8b
Biogen Inc. discovers, develops, manufactures, and delivers therapies in the United States, Europe, Germany, Asia, and internationally.
BIIB
US$195.13
7D
-0.3%
1Y
36.0%
BioNTech
Market Cap: US$27.6b
A biotechnology company, develops and commercializes immunotherapies to treat cancer and infectious diseases in Germany.
BNTX
US$110.89
7D
3.6%
1Y
-0.08%
Royalty Pharma
Market Cap: US$26.2b
Operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States.
RPRX
US$45.40
7D
-0.02%
1Y
34.8%
United Therapeutics
Market Cap: US$20.4b
A biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally.
UTHR
US$473.43
7D
-1.9%
1Y
32.4%
Incyte
Market Cap: US$20.1b
A biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics in the United States, Europe, Canada, and Japan.
INCY
US$101.05
7D
-0.1%
1Y
35.8%
Revolution Medicines
Market Cap: US$20.0b
A clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers.
RVMD
US$104.83
7D
4.2%
1Y
153.6%
Moderna
Market Cap: US$19.9b
A biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally.
MRNA
US$50.52
7D
15.0%
1Y
51.8%
Exact Sciences
Market Cap: US$19.7b
Provides cancer screening and diagnostic test products in the United States and internationally.
EXAS
US$103.45
7D
0.1%
1Y
106.2%
Illumina
Market Cap: US$18.4b
Provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa.
ILMN
US$122.90
7D
5.5%
1Y
28.3%
Viatris
Market Cap: US$18.4b
Operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East.
VTRS
US$16.07
7D
2.1%
1Y
39.9%
Ascendis Pharma
Market Cap: US$14.4b
Operates as a biopharmaceutical company that focuses on developing TransCon-based therapies for unmet medical needs in Europe, the United States, and internationally.
ASND
US$234.99
7D
5.2%
1Y
55.1%
Ionis Pharmaceuticals
Market Cap: US$13.7b
A commercial-stage biotechnology company, provides RNA-targeted medicines in the United States.
IONS
US$85.45
7D
5.0%
1Y
168.3%
Neurocrine Biosciences
Market Cap: US$12.9b
Neurocrine Biosciences, Inc. discovers, develops, and commercialize pharmaceuticals for neurological, psychiatric, endocrine, and immunological disorders in the United States and internationally.
NBIX
US$130.96
7D
2.5%
1Y
13.0%
Medpace Holdings
Market Cap: US$12.6b
Provides clinical research-based drug and medical device development services in North America, Europe, Asia, South America, Africa, and Australia.
MEDP
US$442.20
7D
3.3%
1Y
29.7%
Summit Therapeutics
Market Cap: US$12.4b
A biopharmaceutical company, focuses on discovery, development, and commercialization of patient, physician, caregiver, and societal friendly medicinal therapies.
SMMT
US$16.12
7D
2.8%
1Y
-11.0%
Elanco Animal Health
Market Cap: US$12.3b
An animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide.
ELAN
US$26.38
7D
6.1%
1Y
146.5%